VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

ISA 2022 | ISA highlights: early diagnosis & clearing amyloid deposits from affected organs

Jonathan Wall, PhD, University of Tennessee Graduate School of Medicine, Knoxville, TN, shares some of the key themes discussed at the ISA meeting, including using imaging to detect amyloid deposits early in the disease course, and finding strategies to directly remove amyloid deposits from affected organs and tissues. This interview took place at the 2022 International Symposium on Amyloidosis (ISA) held in Heidelberg, Germany.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Disclosures

Co-founder and shareholder in Attralus Inc. Inventor and patent holder related to amyloid-binding peptide technologies and amyloid-reactive antibody. Receive research funding from Attralus Inc.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter